Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial von Meng, Xue, Zheng, Anping, Wang, Jun, Wu, Xiaoyuan, Li, Guang, Zhu, Jun, Ma, Hu, Zhu, Xiaodong, Shi, Anhui, Dai, Chunhua, Yan, Senxiang, Wang, Buhai, Qu, Zhongyu, Han, Chun, Sun, Xindong, Ye, Ming, Fan, Ruitai, Huerxidan, Niyazi, Wang, Xiaohong, Yu, Jinming

Volltext

Efficacy and Safety of Iparomlimab, an Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors: A Phase 1c Study von Xiong, Jianping, Ouyang, Weiwei, Yang, Mengxiang, Gao, Zhenyuan, Zhou, Huan, Lou, Hanmei, Guo, Yabing, Xu, Zhongyuan, Zheng, Ling, Liu, Ying, Wang, Zhongfeng, Sun, Ping, Niyazi, Huerxidan, Wang, Jianhua, Chen, Yan, Zhang, Baihui, Li, Lingyan, Kang, Xiaoyan, Guo, Weijian

Volltext

The expression level and prognostic value of PD-L1 and PD-1 in cervical carcinoma patients von Zhang, Songan, Bao, Yong Xing, Huerxidan, Niyazi, Liu, Pan, Zhao, Huarong, Gulixian, Tuluwengjiang, Zhang, Yang, Xiao, Lei, Su, Weipeng, Dilidaer, Sidike, Ye, Jianwei

Volltext